Please assess the completion status of the following clinical trial:

Trial Title: Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Able to read and understand English~* Has a BioFlo implanted port in place less than one (1) year~* Evidence of a patent BioFlo port catheter prior to enrollment in the study~* Is receiving active treatment (i.e., receiving a therapeutic drug) through the BioFlo implanted port~* Current treatment protocol projected to continue for a minimum of three (3) months~* Anticipates receiving care at the identified centers for 12 months following enrollment in the study~* Does not receive care of BioFlo implanted port at any other facility~Exclusion Criteria:~* Has documented heparin platelet antibody (i.e., could not be randomized to either group) or other allergy to heparin~* Receiving therapeutic dose of an anticoagulant (e.g.,warfarin, heparin, enoxaparin)~* Does not meet one or more of the inclusion criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: ACTIVE_COMPARATOR): Heparinized saline catheter flush - The control group will have their port catheters flushed with 20mL saline + 5mL heparin 100 units/mL; q 3 months
- Intervention Group (Type: EXPERIMENTAL): Saline-only catheter flush - The intervention group will have their port catheters flushed with saline only.

Based on this trial design, predict the completion outcome and termination type (if applicable).